Breaking News

Thursday
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
CLVS

Clovis

$54.93

1.22 (2.27%)

, TSRO

Tesaro

$62.01

-0.29 (-0.47%)

11:22
02/22/18
02/22
11:22
02/22/18
11:22
Hot Stocks
Clovis jumps as analysts get more bullish following EU advisory news »

Shares of Clovis (CLVS)…

CLVS

Clovis

$54.93

1.22 (2.27%)

TSRO

Tesaro

$62.01

-0.29 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

PANW

Palo Alto Networks

$164.48

0.08 (0.05%)

, VRSK

Verisk Analytics

$99.23

2.19 (2.26%)

10:26
02/22/18
02/22
10:26
02/22/18
10:26
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…

PANW

Palo Alto Networks

$164.48

0.08 (0.05%)

VRSK

Verisk Analytics

$99.23

2.19 (2.26%)

TSRO

Tesaro

$62.01

-0.29 (-0.47%)

CLVS

Clovis

$54.93

1.22 (2.27%)

WWW

Wolverine World Wide

$30.50

0.99 (3.35%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 26

    Feb

  • 26

    Feb

  • 27

    Feb

  • 04

    Mar

  • 14

    Mar

  • 19

    Mar

  • 19

    Apr

CLVS

Clovis

$54.93

1.22 (2.27%)

, TSRO

Tesaro

$62.01

-0.29 (-0.47%)

09:04
02/22/18
02/22
09:04
02/22/18
09:04
Upgrade
Clovis, Tesaro rating change  »

Evercore ISI upgrades…

CLVS

Clovis

$54.93

1.22 (2.27%)

TSRO

Tesaro

$62.01

-0.29 (-0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

  • 27

    Feb

TSRO

Tesaro

$62.01

-0.29 (-0.47%)

06:37
02/22/18
02/22
06:37
02/22/18
06:37
Upgrade
Tesaro rating change at Evercore ISI »

Tesaro upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Feb

Over a week ago
MRK

Merck

$55.46

-0.94 (-1.67%)

, REGN

Regeneron

$338.80

6.82 (2.05%)

04:55
02/07/18
02/07
04:55
02/07/18
04:55
Conference/Events
Drug Information Association to hold a forum »

Regulatory Submissions,…

MRK

Merck

$55.46

-0.94 (-1.67%)

REGN

Regeneron

$338.80

6.82 (2.05%)

LXRX

Lexicon

$9.78

0.46 (4.94%)

ACN

Accenture

$154.69

2.86 (1.88%)

ALPMY

Astellas Pharma

$13.25

0.125 (0.95%)

TSRO

Tesaro

$60.16

1.85 (3.17%)

NBRV

Nabriva Therapeutics

$5.68

-0.05 (-0.87%)

BMY

Bristol-Myers

$60.90

-0.06 (-0.10%)

BAYRY

Bayer

$31.20

1.335 (4.47%)

ALXN

Alexion

$114.91

2.19 (1.94%)

CAH

Cardinal Health

$65.44

1.1 (1.71%)

AMGN

Amgen

$176.65

1.9 (1.09%)

INO

Inovio

$4.22

0.12 (2.93%)

OTEX

OpenText

$35.55

-0.32 (-0.89%)

PFE

Pfizer

$35.28

0.61 (1.76%)

JNJ

Johnson & Johnson

$131.83

1.44 (1.10%)

TEVA

Teva

$20.40

0.66 (3.34%)

GSK

GlaxoSmithKline

$35.99

0.5 (1.41%)

AZN

AstraZeneca

$34.30

0.52 (1.54%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 12

    Feb

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 05

    Mar

  • 08

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 17

    May

  • 23

    May

  • 28

    May

  • 23

    Oct

MRK

Merck

$56.40

-2.16 (-3.69%)

, REGN

Regeneron

$331.98

-15.88 (-4.57%)

04:55
02/06/18
02/06
04:55
02/06/18
04:55
Conference/Events
Drug Information Association to hold a forum »

Regulatory Submissions,…

MRK

Merck

$56.40

-2.16 (-3.69%)

REGN

Regeneron

$331.98

-15.88 (-4.57%)

LXRX

Lexicon

$9.32

-0.445 (-4.56%)

ACN

Accenture

$151.83

-5.07 (-3.23%)

ALPMY

Astellas Pharma

$13.13

-0.2649 (-1.98%)

TSRO

Tesaro

$58.31

-1.63 (-2.72%)

NBRV

Nabriva Therapeutics

$5.73

-0.1 (-1.72%)

BMY

Bristol-Myers

$60.96

-2.52 (-3.97%)

BAYRY

Bayer

$29.87

-1.72 (-5.45%)

ALXN

Alexion

$112.72

-3.43 (-2.95%)

CAH

Cardinal Health

$64.34

-3.12 (-4.63%)

AMGN

Amgen

$174.75

-12.26 (-6.56%)

INO

Inovio

$4.10

-0.15 (-3.53%)

OTEX

OpenText

$35.87

-0.63 (-1.73%)

PFE

Pfizer

$34.67

-1.94 (-5.30%)

JNJ

Johnson & Johnson

$130.39

-7.29 (-5.29%)

TEVA

Teva

$19.74

-0.83 (-4.04%)

GSK

GlaxoSmithKline

$35.49

-1.61 (-4.34%)

AZN

AstraZeneca

$33.78

-2.12 (-5.91%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 12

    Feb

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 05

    Mar

  • 08

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 17

    May

  • 23

    May

  • 28

    May

  • 23

    Oct

MRK

Merck

$58.56

-1.3 (-2.17%)

, REGN

Regeneron

$347.86

2.07 (0.60%)

07:08
02/05/18
02/05
07:08
02/05/18
07:08
Conference/Events
Drug Information Association to hold a forum »

Regulatory Submissions,…

MRK

Merck

$58.56

-1.3 (-2.17%)

REGN

Regeneron

$347.86

2.07 (0.60%)

LXRX

Lexicon

$9.77

-0.13 (-1.31%)

ACN

Accenture

$156.90

-3.56 (-2.22%)

ALPMY

Astellas Pharma

$13.39

-0.1851 (-1.36%)

TSRO

Tesaro

$59.94

-3.46 (-5.46%)

NBRV

Nabriva Therapeutics

$5.83

-0.45 (-7.17%)

BMY

Bristol-Myers

$63.48

0.68 (1.08%)

BAYRY

Bayer

$31.59

-0.825 (-2.55%)

ALXN

Alexion

$116.15

-1.94 (-1.64%)

CAH

Cardinal Health

$67.46

-1.6 (-2.32%)

AMGN

Amgen

$187.01

1.45 (0.78%)

INO

Inovio

$4.25

-0.17 (-3.85%)

OTEX

OpenText

$36.50

-2.1 (-5.44%)

PFE

Pfizer

$36.61

-0.22 (-0.60%)

JNJ

Johnson & Johnson

$137.68

-2.34 (-1.67%)

TEVA

Teva

$20.57

-0.61 (-2.88%)

GSK

GlaxoSmithKline

$37.10

-0.49 (-1.30%)

AZN

AstraZeneca

$35.90

0.76 (2.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 05

    Feb

  • 06

    Feb

  • 06

    Feb

  • 07

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 08

    Feb

  • 12

    Feb

  • 16

    Feb

  • 16

    Feb

  • 19

    Feb

  • 26

    Feb

  • 27

    Feb

  • 27

    Feb

  • 05

    Mar

  • 08

    Mar

  • 08

    Mar

  • 25

    Mar

  • 03

    Apr

  • 23

    Apr

  • 30

    Apr

  • 17

    May

  • 23

    May

  • 28

    May

  • 23

    Oct

TSRO

Tesaro

$63.40

-4.06 (-6.02%)

12:10
02/02/18
02/02
12:10
02/02/18
12:10
Hot Stocks
Vanguard Specialized Funds reports 5.51% passive stake in TESARO »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Feb

  • 27

    Feb

Over a month ago
TSRO

Tesaro

$61.86

-3.66 (-5.59%)

09:05
01/18/18
01/18
09:05
01/18/18
09:05
Recommendations
Tesaro analyst commentary at Credit Suisse »

Tesaro price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRTX

Heron Therapeutics

$21.40

-0.25 (-1.15%)

, TSRO

Tesaro

$69.59

-2.07 (-2.89%)

09:03
01/16/18
01/16
09:03
01/16/18
09:03
Recommendations
Heron Therapeutics, Tesaro analyst commentary at Cowen »

Tesaro Varubi setback an…

HRTX

Heron Therapeutics

$21.40

-0.25 (-1.15%)

TSRO

Tesaro

$69.59

-2.07 (-2.89%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.